Document is current
Any future updates will be listed below
-
Authors
Bordeaux, Zachary A. https://orcid.org/0000-0002-8833-6080
Reddy, Sriya V. https://orcid.org/0000-0002-7584-7594
Choi, Justin https://orcid.org/0000-0002-8388-6876
Braun, Gabriella https://orcid.org/0000-0003-4496-3696
McKeel, Jaimie https://orcid.org/0000-0003-2528-7020
Lu, Weiying https://orcid.org/0000-0003-1539-2708
Yossef, Selina M. https://orcid.org/0009-0008-2463-9438
Ma, Emily Z. https://orcid.org/0000-0001-6022-6659
West, Cameron E. https://orcid.org/0000-0001-9673-9165
Kwatra, Shawn G. https://orcid.org/0000-0003-3736-1515
Kwatra, Madan M. https://orcid.org/0000-0002-6547-8852
-
Funding
Funding for this research was provided by:
Genzada Pharmecuticals
- License Information
-
More Information
Article History
Received: 25 September 2023
Accepted: 19 January 2024
First Online: 23 January 2024
Competing interests
: Dr. S.G. Kwatra is an advisory board member/consultant for Abbvie, Aslan Pharmaceuticals, Arcutis Biotherapeutics, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte Corporation, Johnson & Johnson, Novartis Pharmaceuticals Corporation, Pfizer, Regeneron Pharmaceuticals, and Sanofi and has served as an investigator for Galderma, Incyte, Pfizer, and Sanofi. Dr. West is an officer of and Director at Genzada Pharmaceuticals. The remaining authors have no competing interests to disclose.
